查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403391

總體基因體學市場至2030年的預測：按產品類型、技術、應用、最終用戶和地區進行的全球分析

Metagenomics Market Forecasts to 2030 - Global Analysis By Product Type (Kits & Reagents, Software, Sequencing & Data Analytics Services and Other Product Types), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2023年全球總體基因體學市場規模將達20億美元，預計在預測期內年複合成長率為18.5%，到2030年將達到65億美元。

從環境樣本中提取遺傳物質的研究稱為總體基因體學。這項研究的特點是作為微生物群落研究遺傳和微生物途徑的工具。這提供了一個強大的鏡頭，能夠理解整個生命宇宙。科技使研究人員能夠接觸到各種的微生物，使他們能夠更佳了解微生物生態系統。

根據美國國家人類基因組研究所截至2017年 7月的報告，對一個人類基因組序列測定大約需要 743 Terabyte（743,000 GB）的資料，而2001年人類基因計劃啟動時將產生 16.2 GB 的資料。

臨床應用需求不斷增加

總體基因體學在疾病診斷、個人化醫療以及了解人類微生物組在健康和疾病中的作用的臨床實踐中取得進展。它能夠對微生物群落進行全面分析，有助於疾病識別、治療最佳化和藥物開發。這些生物標記有潛力作為各種疾病的診斷指標和治療標靶。這些都是推動市場成長的因素。

道德和監管問題

敏感資訊的管理引起了必須解決的道德和隱私問題，特別是與人類微生物組資料的使用相關的問題。此外，管理遺傳和資料使用的法律的地區差異資料商業化和研究舉措。此外，管理、儲存和解讀此類資料可能很困難，並且需要專業知識，這可能會進一步阻礙市場擴張。

提高意識和研究舉措

人們越來越關注微生物組對農業、人類健康和環境的影響，導致資金籌措和研究計劃的增加。由於技術和分析技術的進步，總體基因體學學領域迅速發展。由於新的發現和見解，對微生物群落的了解不斷成長。由於政府機構、學術機構和商業公司的資助不斷增加，總體基因體學研究市場不斷成長。

與定序技術相關的高成本

資料分析、電腦資源和定序技術的高昂成本是小型研究機構和預算有限的公司使用它們的主要障礙。總體基因體學研究產生大量資料，需要先進的計算基礎設施和生物資訊知識。評估各種微生物群落的挑戰之一是它們的複雜性。這是阻礙市場拓展的因素。

COVID-19 的影響：

借助總體基因體學，識別並檢測到了導致 COVID-19 的 SARS-CoV-2。研究人員利用總體基因體學分析來追蹤突變、發現新病毒株並了解病毒的傳播。總體基因體學對於製造疫苗很有用，因為它揭示了病毒的基因組成。科學家們利用這些知識，透過更佳了解病毒如何隨時間變化並開發免疫接種來提高疫苗的有效性。

套件和試劑區隔預計將在預測期內成為最大的區隔

套件和試劑區隔預計將成為預測期內最大的區隔。這些套件提供標準化的方法和試劑，以確保實驗過程的一致性和重現性。這減少了實驗和研究之間的差異。這些套件效果更好，因為它們是針對特定樣本類型和定序平台量身定做的。許多零件專為困難樣品而設計，可提高 DNA產量和純度。

預測期內，霰彈槍定序領域預估年複合成長率最高

預計霰彈槍定序產業在預測期內將經歷最高的年複合成長率。霰彈槍定序是公平的，因為它不需要事先了解樣本中存在的物種。因為它捕獲了所有遺傳資訊，所以可以發現新的和意想不到的物種。它有助於為更有針對性的研究提出假設。透過識別群落的遺傳潛力，研究人員可以致力於感興趣的特定基因和途徑進行詳細研究。

佔比最大的地區：

預計北美在預測期內將佔據最大的市場佔有率。在這些棲息地中，透過總體基因體學對遺傳多樣性進行廣泛分析有助於了解存在的各種生物體。該地區處於技術進步的前沿。定序和計算技術的技術發展允許對複雜的微生物種群進行更深入的探索和理解，促進了總體基因體學研究。

年複合成長率最高的地區：

預計亞太地區在預測期內將維持最高的年複合成長率。在中國、印度和日本等國家，調查土壤健康、發現對農業有用的微生物以及解決河流和海洋污染等環境問題，都透過總體基因體學的使用而得到促進。總體基因體學在了解人口稠密的大都會圈發現的微生物群落、促進疾病監測和檢查人類微生物組的多樣性方面發揮著重要作用。

  • 其他產品類型

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球總體基因體學市場：依產品類型

  • 套件和試劑
  • 軟體
  • 定序和資料分析服務
  • 樣品庫製備試劑套件
  • 樣品萃取套件
  • 總體基因體學定序試劑套件
  • 其他產品類型

第6章 全球總體基因體學市場：依技術分類

  • 16S序列
  • 全基因組序列測定
  • 霰彈槍序列
  • 元轉錄組學
  • 其他技術

第7章 全球總體基因體學市場：依應用分類

  • 生物介面活性劑和抗生素的生產
  • 臨床診斷
  • 微生物多樣性
  • 生物修復和分解
  • 其他用途

第8章 全球總體基因體學市場：依最終用戶分類

  • 病理實驗室
  • 學術研究所
  • 調查
  • 生物技術
  • 藥品
  • 食品和營養
  • 其他最終用戶

第9章 全球總體基因體學市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Agilent Technologies
  • BGI Group
  • Bio-Rad Laboratories
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • IntegraGen
  • Merck KGaA
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Trivitron Healthcare Pvt. Ltd.
Product Code: SMRC24616

According to Stratistics MRC, the Global Metagenomics Market is accounted for $2.0 billion in 2023 and is expected to reach $6.5 billion by 2030 growing at a CAGR of 18.5% during the forecast period. The study of genetic material extracted from environmental samples is known as metagenomics. To investigate genes and microbial pathways, the research is characterized as a tool for the microbial community. It offers a strong lens with the capacity to comprehend the entirety of the living universe. Researchers may now access a wide range of microbial variety and gain a better grasp of the microbial ecology thanks to technology.

According to a report from the National Human Genome Research Institute as of July 2017, approximately 743 terabytes (743,000 gigabytes) of data are generated during the sequencing of a single human genome, compared to 16.2 gigabytes at the beginning of the human genome project in 2001.

Market Dynamics:

Driver:

Rising demand in clinical applications

Metagenomics has gained traction in clinical settings for disease diagnostics, personalized medicine, and understanding the human microbiome's role in health and disease. It allows for comprehensive analysis of microbial communities, aiding in disease identification, treatment optimization, and drug development. These biomarkers could potentially serve as diagnostic indicators or therapeutic targets for various conditions. These are the factors propelling the growth of the market.

Restraint:

Ethical and regulatory concerns

The management of sensitive information raises ethical and privacy concerns that must be addressed, particularly with relation to the use of human microbiome data. Furthermore, regional differences in the laws governing the use of genetic and microbiological data have an effect on commercialization and research initiatives. Furthermore, managing, preserving, and deciphering this data might be difficult and call for specific knowledge, which could further impede the market's expansion.

Opportunity:

Increasing awareness and research initiatives

Growing apprehension about the effects of microbiomes on agriculture, human health, and the environment has resulted in more financing and research projects. The area of metagenomics is developing quickly due to ongoing advances in technology and analytical techniques. The understanding of microbial communities is always growing as a result of new findings and insights. The market for metagenomics research is growing as a result of increased funding from governmental bodies, academic institutions, and commercial businesses.

Threat:

High costs associated with sequencing technologies

The high expense of data analysis, computer resources, and sequencing technology is a major hurdle that prevents smaller research organizations or businesses with tighter budgets from using them. Metagenomic investigations create enormous amounts of data, which calls for advanced computing infrastructure and bioinformatics knowledge. One of the challenges in evaluating various microbial communities is their complexity. This is the element impeding the market's expansion.

COVID-19 Impact:

us that causes COVID-19, SARS-CoV-2, has been identified and detected thanks in large part to metagenomics. Metagenomic sequencing has been utilized by researchers to track mutations, find new strains, and comprehend the virus's dissemination. Because it sheds light on the virus's genetic composition, metagenomics has aided in the creation of vaccines. Scientists have used this knowledge to better understand how the virus could change over time and develop vaccinations, which has improved vaccine effectiveness.

The kits & reagents segment is expected to be the largest during the forecast period

The kits & reagents segment is expected to be the largest during the forecast period. Standardized methods and reagents are provided by these kits, guaranteeing uniformity and repeatability in experimental processes. This lessens variation across experiments and amongst researchers. These kits work better because they are tailored for particular kinds of samples or sequencing platforms. They frequently have parts designed specifically for difficult sample kinds, enhancing DNA yield and purity.

The shotgun sequencing segment is expected to have the highest CAGR during the forecast period

The shotgun sequencing segment is expected to have the highest CAGR during the forecast period. Without requiring prior knowledge of the species present in the sample, shotgun sequencing is impartial. Since it captures all genetic information, new and unexpected species can be found. It helps to produce hypotheses for more focused research. Researchers might concentrate on particular genes or pathways of interest for in-depth studies by identifying a community's genetic potential.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. Understanding the wide variety of organisms present is made easier by the extensive analysis of genetic diversity provided by metagenomics in these habitats. The area is leading the way in technical advancements. Technological developments in sequencing and computational techniques facilitate metagenomic research by enabling deeper examination and comprehension of intricate microbial populations.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. Researching soil health, discovering useful microbes for agriculture, and addressing environmental issues like pollution in rivers and seas in nations such as China, India, and Japan are all made easier by the use of metagenomics. Metagenomics plays a crucial role in comprehending the microbial communities found in highly populated metropolitan regions, facilitating disease surveillance, and examining the variety of the human microbiome.

Key players in the market:

Some of the key players in Metagenomics market include Agilent Technologies, BGI Group, Bio-Rad Laboratories, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Illumina, Inc., IntegraGen, Merck KGaA, Novogene Co., Ltd., Oxford Nanopore Technologies, PerkinElmer, Inc., Promega Corporation, Qiagen, Takara Bio, Inc., Thermo Fisher Scientific, Inc. and Trivitron Healthcare Pvt. Ltd.

Key Developments:

In September 2022, Illumina, Inc. (US) launched the NovaSeq X series production-scale sequencers, which are capable of generating more than 20,000 whole genomes per year (which is 2.5 times the throughput of prior sequencers from Illumina).

In September 2021, Thermo Fisher Scientific, Inc. (US) and AstraZeneca(UK) co-developed an NGS-based companion diagnostic. The collaboration was focused on commercializing NGS-based diagnostics in Russia.

Product Types Covered:

  • Kits & Reagents
  • Software
  • Sequencing & Data Analytics Services

Library Preparation Kits

Sample Extraction Kits

Metagenomic Sequencing Kits

  • Other Product Types

Technologies Covered:

  • 16S Sequencing
  • Whole Genome Sequencing
  • Shotgun Sequencing
  • Metatranscriptomics
  • Other Technologies

Applications Covered:

  • Bio Surfactants and Antibiotics Production
  • Clinical Diagnostics
  • Microbial Diversity
  • Bioremediation and Degradation
  • Other Applications

End Users Covered:

  • Pathology Laboratories
  • Academic and Research Institutes
  • Biotechnology
  • Pharmaceutical
  • Food & Nutrition
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Metagenomics Market, By Product Type

  • 5.1 Introduction
  • 5.2 Kits & Reagents
  • 5.3 Software
  • 5.4 Sequencing & Data Analytics Services
  • 5.5 Library Preparation Kits
  • 5.6 Sample Extraction Kits
  • 5.7 Metagenomic Sequencing Kits
  • 5.8 Other Product Types

6 Global Metagenomics Market, By Technology

  • 6.1 Introduction
  • 6.2 16S Sequencing
  • 6.3 Whole Genome Sequencing
  • 6.4 Shotgun Sequencing
  • 6.5 Metatranscriptomics
  • 6.6 Other Technologies

7 Global Metagenomics Market, By Application

  • 7.1 Introduction
  • 7.2 Bio Surfactants and Antibiotics Production
  • 7.3 Clinical Diagnostics
  • 7.4 Microbial Diversity
  • 7.5 Bioremediation and Degradation
  • 7.6 Other Applications

8 Global Metagenomics Market, By End User

  • 8.1 Introduction
  • 8.2 Pathology Laboratories
  • 8.3 Academic and Research Institutes
  • 8.4 Research Laboratories
  • 8.5 Biotechnology
  • 8.6 Pharmaceutical
  • 8.7 Food & Nutrition
  • 8.8 Other End Users

9 Global Metagenomics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Agilent Technologies
  • 11.2 BGI Group
  • 11.3 Bio-Rad Laboratories
  • 11.4 Eurofins Scientific
  • 11.5 F. Hoffmann-La Roche Ltd.
  • 11.6 Illumina, Inc.
  • 11.7 IntegraGen
  • 11.8 Merck KGaA
  • 11.9 Novogene Co., Ltd.
  • 11.10 Oxford Nanopore Technologies
  • 11.11 PerkinElmer, Inc.
  • 11.12 Promega Corporation
  • 11.13 Qiagen
  • 11.14 Takara Bio, Inc.
  • 11.15 Thermo Fisher Scientific, Inc.
  • 11.16 Trivitron Healthcare Pvt. Ltd.

List of Tables

  • Table 1 Global Metagenomics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Metagenomics Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Metagenomics Market Outlook, By Kits & Reagents (2021-2030) ($MN)
  • Table 4 Global Metagenomics Market Outlook, By Software (2021-2030) ($MN)
  • Table 5 Global Metagenomics Market Outlook, By Sequencing & Data Analytics Services (2021-2030) ($MN)
  • Table 6 Global Metagenomics Market Outlook, By Library Preparation Kits (2021-2030) ($MN)
  • Table 7 Global Metagenomics Market Outlook, By Sample Extraction Kits (2021-2030) ($MN)
  • Table 8 Global Metagenomics Market Outlook, By Metagenomic Sequencing Kits (2021-2030) ($MN)
  • Table 9 Global Metagenomics Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 10 Global Metagenomics Market Outlook, By Technology (2021-2030) ($MN)
  • Table 11 Global Metagenomics Market Outlook, By 16S Sequencing (2021-2030) ($MN)
  • Table 12 Global Metagenomics Market Outlook, By Whole Genome Sequencing (2021-2030) ($MN)
  • Table 13 Global Metagenomics Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 14 Global Metagenomics Market Outlook, By Metatranscriptomics (2021-2030) ($MN)
  • Table 15 Global Metagenomics Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 16 Global Metagenomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Metagenomics Market Outlook, By Bio Surfactants and Antibiotics Production (2021-2030) ($MN)
  • Table 18 Global Metagenomics Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
  • Table 19 Global Metagenomics Market Outlook, By Microbial Diversity (2021-2030) ($MN)
  • Table 20 Global Metagenomics Market Outlook, By Bioremediation and Degradation (2021-2030) ($MN)
  • Table 21 Global Metagenomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 22 Global Metagenomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 23 Global Metagenomics Market Outlook, By Pathology Laboratories (2021-2030) ($MN)
  • Table 24 Global Metagenomics Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 25 Global Metagenomics Market Outlook, By Research Laboratories (2021-2030) ($MN)
  • Table 26 Global Metagenomics Market Outlook, By Biotechnology (2021-2030) ($MN)
  • Table 27 Global Metagenomics Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 28 Global Metagenomics Market Outlook, By Food & Nutrition (2021-2030) ($MN)
  • Table 29 Global Metagenomics Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.